nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0962	0.282	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.065	0.19	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.062	0.182	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0552	0.162	CbGbCtD
Chenodeoxycholic acid—CYP27A1—leg—chronic obstructive pulmonary disease	0.0328	0.437	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0324	0.095	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0306	0.0897	CbGbCtD
Chenodeoxycholic acid—CYP27A1—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0275	0.166	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—connective tissue—chronic obstructive pulmonary disease	0.00984	0.131	CbGeAlD
Chenodeoxycholic acid—CYP27A1—respiratory system—chronic obstructive pulmonary disease	0.00814	0.109	CbGeAlD
Chenodeoxycholic acid—CYP27A1—connective tissue—chronic obstructive pulmonary disease	0.00716	0.0956	CbGeAlD
Chenodeoxycholic acid—CYP27A1—bronchus—chronic obstructive pulmonary disease	0.0067	0.0894	CbGeAlD
Chenodeoxycholic acid—CYP27A1—trachea—chronic obstructive pulmonary disease	0.00601	0.0802	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00474	0.0285	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—lung—chronic obstructive pulmonary disease	0.00432	0.0577	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00419	0.0252	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00356	0.0214	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00343	0.0207	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00343	0.0206	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00315	0.0189	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.0031	0.0186	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00305	0.0183	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00298	0.0179	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00294	0.0177	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00273	0.0164	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00259	0.0156	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00242	0.0145	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00229	0.0137	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00222	0.0133	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00218	0.0131	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00217	0.013	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00214	0.0129	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00177	0.0106	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00176	0.0106	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00174	0.0105	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00162	0.00974	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00158	0.00953	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00155	0.0093	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00153	0.00919	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00146	0.00876	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00144	0.00864	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00143	0.00857	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00139	0.00836	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00133	0.00802	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.00133	0.008	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00128	0.00773	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00128	0.00772	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00128	0.0077	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00127	0.00762	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.00124	0.00747	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00122	0.00732	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.0012	0.00724	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00119	0.00715	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00113	0.00679	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00112	0.00671	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00109	0.00653	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00107	0.00644	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00106	0.00635	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00103	0.00622	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.001	0.00601	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000984	0.00592	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000982	0.00591	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000975	0.00587	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000971	0.00584	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000954	0.00574	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000939	0.00565	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000933	0.00561	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00092	0.00554	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000898	0.0054	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000867	0.00522	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000834	0.00502	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000817	0.00492	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000794	0.00477	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000793	0.00477	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000783	0.00471	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000783	0.00471	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000766	0.00461	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000752	0.00452	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000751	0.00452	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000751	0.00452	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000738	0.00444	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000723	0.00435	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000719	0.00433	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000704	0.00423	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000696	0.00418	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000682	0.0041	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000658	0.00396	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000653	0.00393	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000627	0.00377	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000594	0.00357	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000585	0.00352	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000577	0.00347	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000556	0.00335	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000549	0.0033	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000549	0.0033	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000546	0.00328	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000535	0.00322	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000525	0.00316	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000511	0.00307	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000497	0.00299	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000493	0.00297	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000491	0.00296	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000488	0.00293	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000484	0.00291	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000481	0.00289	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00113	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.00113	CcSEcCtD
Chenodeoxycholic acid—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00113	CcSEcCtD
Chenodeoxycholic acid—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00047	0.00112	CcSEcCtD
Chenodeoxycholic acid—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000466	0.00112	CcSEcCtD
Chenodeoxycholic acid—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.00112	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00111	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000465	0.0028	CbGpPWpGaD
Chenodeoxycholic acid—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00111	CcSEcCtD
Chenodeoxycholic acid—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.00111	CcSEcCtD
Chenodeoxycholic acid—Infection—Formoterol—chronic obstructive pulmonary disease	0.000463	0.00111	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.0011	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.0011	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.0011	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000459	0.0011	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00109	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00109	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00109	CcSEcCtD
Chenodeoxycholic acid—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00109	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000455	0.00109	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000455	0.00109	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00109	CcSEcCtD
Chenodeoxycholic acid—Infection—Montelukast—chronic obstructive pulmonary disease	0.000453	0.00109	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00108	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00108	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00108	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00045	0.00271	CbGpPWpGaD
Chenodeoxycholic acid—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00108	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000448	0.0027	CbGpPWpGaD
Chenodeoxycholic acid—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000448	0.00107	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00107	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00106	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000442	0.00266	CbGpPWpGaD
Chenodeoxycholic acid—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.00105	CcSEcCtD
Chenodeoxycholic acid—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00105	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00104	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00104	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00104	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00104	CcSEcCtD
Chenodeoxycholic acid—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.00104	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00103	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00103	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00102	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00102	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00102	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000425	0.00256	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00102	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00102	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00101	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00101	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.001	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000419	0.00252	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000419	0.001	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000416	0.000996	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000415	0.000995	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.000995	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.000992	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000414	0.000992	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000413	0.000989	CcSEcCtD
Chenodeoxycholic acid—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000411	0.000985	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.000985	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.000982	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00041	0.000982	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00041	0.000982	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.000978	CcSEcCtD
Chenodeoxycholic acid—Injury—Prednisone—chronic obstructive pulmonary disease	0.000406	0.000972	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000406	0.000972	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000405	0.00097	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000404	0.000967	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000402	0.000964	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.000964	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000402	0.000962	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.000962	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000402	0.000962	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00096	CcSEcCtD
Chenodeoxycholic acid—Pain—Formoterol—chronic obstructive pulmonary disease	0.000398	0.000954	CcSEcCtD
Chenodeoxycholic acid—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.000954	CcSEcCtD
Chenodeoxycholic acid—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.000954	CcSEcCtD
Chenodeoxycholic acid—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000398	0.000954	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.000953	CcSEcCtD
Chenodeoxycholic acid—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000951	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000946	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000394	0.000944	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000393	0.000942	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00094	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000391	0.00235	CbGpPWpGaD
Chenodeoxycholic acid—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.000937	CcSEcCtD
Chenodeoxycholic acid—Pain—Montelukast—chronic obstructive pulmonary disease	0.00039	0.000935	CcSEcCtD
Chenodeoxycholic acid—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00039	0.000934	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.000932	CcSEcCtD
Chenodeoxycholic acid—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.000929	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.000928	CcSEcCtD
Chenodeoxycholic acid—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.000925	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000386	0.00232	CbGpPWpGaD
Chenodeoxycholic acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.000924	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000385	0.000921	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00092	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00092	CcSEcCtD
Chenodeoxycholic acid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000384	0.000919	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.000916	CcSEcCtD
Chenodeoxycholic acid—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000382	0.000916	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.000914	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000381	0.000913	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.000913	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00091	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000909	CcSEcCtD
Chenodeoxycholic acid—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.000901	CcSEcCtD
Chenodeoxycholic acid—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.000901	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000373	0.000894	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000894	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.000887	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00037	0.000887	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000368	0.000882	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.000882	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.000882	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000368	0.000882	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.000879	CcSEcCtD
Chenodeoxycholic acid—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.000872	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.000871	CcSEcCtD
Chenodeoxycholic acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.000871	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000363	0.00219	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000363	0.000868	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.000868	CcSEcCtD
Chenodeoxycholic acid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000362	0.000866	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000361	0.000864	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000361	0.000864	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00036	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00036	0.000863	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.000862	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000358	0.00216	CbGpPWpGaD
Chenodeoxycholic acid—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.000855	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.000851	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GC—chronic obstructive pulmonary disease	0.000354	0.00213	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.000837	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.000833	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.000833	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.000822	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000343	0.000822	CcSEcCtD
Chenodeoxycholic acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000343	0.000821	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000342	0.00082	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000342	0.00206	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000336	0.000805	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.000801	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000334	0.000801	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00079	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00079	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000788	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000329	0.00198	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000327	0.000784	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.000776	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000323	0.000773	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000319	0.00192	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000319	0.000764	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.000764	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00076	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000757	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000756	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000312	0.000748	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000312	0.00188	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.000746	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000308	0.000738	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.000738	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000308	0.00185	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000302	0.000723	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.000721	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00071	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00071	CcSEcCtD
Chenodeoxycholic acid—Rash—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000704	CcSEcCtD
Chenodeoxycholic acid—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000704	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000703	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000703	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000703	CcSEcCtD
Chenodeoxycholic acid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.000699	CcSEcCtD
Chenodeoxycholic acid—Headache—Formoterol—chronic obstructive pulmonary disease	0.000292	0.000699	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000699	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.000697	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00029	0.000695	CcSEcCtD
Chenodeoxycholic acid—Rash—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000689	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000689	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.000687	CcSEcCtD
Chenodeoxycholic acid—Depression—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000687	CcSEcCtD
Chenodeoxycholic acid—Headache—Montelukast—chronic obstructive pulmonary disease	0.000286	0.000685	CcSEcCtD
Chenodeoxycholic acid—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000679	CcSEcCtD
Chenodeoxycholic acid—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000283	0.000677	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000282	0.0017	CbGpPWpGaD
Chenodeoxycholic acid—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000675	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00028	0.00169	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00067	CcSEcCtD
Chenodeoxycholic acid—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.000668	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000665	CcSEcCtD
Chenodeoxycholic acid—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000664	CcSEcCtD
Chenodeoxycholic acid—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.000664	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000664	CcSEcCtD
Chenodeoxycholic acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000277	0.000663	CcSEcCtD
Chenodeoxycholic acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.000663	CcSEcCtD
Chenodeoxycholic acid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00066	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.000651	CcSEcCtD
Chenodeoxycholic acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000271	0.000649	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.000642	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.000639	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000264	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000262	0.00158	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.000626	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000261	0.00157	CbGpPWpGaD
Chenodeoxycholic acid—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000623	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000259	0.000621	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000618	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000608	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000253	0.00152	CbGpPWpGaD
Chenodeoxycholic acid—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.000604	CcSEcCtD
Chenodeoxycholic acid—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.000595	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00059	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.000584	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000244	0.00147	CbGpPWpGaD
Chenodeoxycholic acid—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000578	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000238	0.00143	CbGpPWpGaD
Chenodeoxycholic acid—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000561	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000558	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000552	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000547	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000546	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.00136	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.000543	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000227	0.00136	CbGpPWpGaD
Chenodeoxycholic acid—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000538	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000224	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.00022	0.00133	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000517	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000212	0.00128	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000209	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000499	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000208	0.00125	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000498	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000497	CcSEcCtD
Chenodeoxycholic acid—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000492	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000205	0.00123	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000485	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000484	CcSEcCtD
Chenodeoxycholic acid—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000483	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00048	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000473	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000466	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000465	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000193	0.00116	CbGpPWpGaD
Chenodeoxycholic acid—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000458	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000458	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000191	0.00115	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000455	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000453	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000445	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00111	CbGpPWpGaD
Chenodeoxycholic acid—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000439	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000183	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000436	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000181	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—Shock—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000432	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000431	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000429	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000427	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000178	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000425	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000419	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000174	0.00105	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000169	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000168	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000167	0.0004	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.0004	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000397	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000394	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000162	0.000972	CbGpPWpGaD
Chenodeoxycholic acid—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000387	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.000965	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00016	0.000961	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00096	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000382	CcSEcCtD
Chenodeoxycholic acid—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000381	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000381	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000379	CcSEcCtD
Chenodeoxycholic acid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000379	CcSEcCtD
Chenodeoxycholic acid—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000376	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000362	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000359	CcSEcCtD
Chenodeoxycholic acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000359	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000349	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000347	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000347	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000324	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000134	0.000808	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000134	0.000805	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.000797	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000132	0.000794	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000315	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000311	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000301	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000123	0.00074	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00029	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00012	0.000724	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000119	0.000716	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.000701	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000279	CcSEcCtD
Chenodeoxycholic acid—Rash—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000277	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000277	CcSEcCtD
Chenodeoxycholic acid—Headache—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000275	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000112	0.000674	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000111	0.000665	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000261	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000109	0.000653	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000108	0.000652	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000104	0.000624	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000103	0.000619	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000102	0.000614	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000102	0.000611	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.000602	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.76e-05	0.000587	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.63e-05	0.000579	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.34e-05	0.000502	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.23e-05	0.000495	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALB—chronic obstructive pulmonary disease	7.93e-05	0.000477	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.85e-05	0.000472	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.67e-05	0.000461	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.58e-05	0.000456	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.27e-05	0.000437	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.2e-05	0.000313	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.06e-05	0.000304	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	4.94e-05	0.000297	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.73e-05	0.000284	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.7e-05	0.000283	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.76e-05	0.000166	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.73e-05	0.000164	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.49e-05	0.00015	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.3e-05	0.000138	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.92e-05	0.000115	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.89e-05	0.000114	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.76e-05	0.000106	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.0001	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.13e-05	6.83e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.09e-05	6.53e-05	CbGpPWpGaD
